Blood-testing startup Theranos said it sent doctors and patients tens of thousands of corrected test results and voided data from its devices for 2014 and 2015, a devastating blow for the company that has come under scrutiny over the accuracy of its technology.

The Silicon Valley startup reported its testing-device problems to federal health regulators at the Centers for Medicare and Medicaid Services, the Wall Street Journal reported. A company spokeswoman confirmed the report.

Theranos is developing a technology that, the company has said, can run scores of diagnostic tests using only a few drops of blood. But the California-based startup has faced questions about whether its technology works, has endured multiple investigations, and its president has left the company.


Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.